The Current Ratio as of September 2024 (TTM) for Valneva SE (VALN) is 2.63

According to Valneva SE’s latest financial reports and current stock price. The company's current Current Ratio is 2.63. This represents a change of 25.23% compared to the average of 2.10 of the last 4 quarters.

Valneva SE (VALN) Historical Current Ratio (quarterly & annually)

How has VALN Current Ratio performed in the past?

The mean historical Current Ratio of Valneva SE over the last ten years is 2.19. The current 2.63 Current Ratio has changed 11.90% with respect to the historical average. Over the past ten years (40 quarters), VALN's Current Ratio was at its highest in in the March 2019 quarter at 4.25. The Current Ratio was at its lowest in in the September 2021 quarter at 0.

Valneva SE (VALN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Valneva SE Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Valneva SE (VALN) Average Current Ratio

How has VALN Current Ratio performed in the past?

The current Current Ratio of Valneva SE (VALN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Valneva SE (VALN) Current Ratio vs. Peers

How is VALN’s Current Ratio compared to its peers?

Valneva SE’s Current Ratio is greater than Advaxis, Inc. (0.30), greater than NuCana plc (1.08), less than Sage Therapeutics, Inc. (9.95), greater than SELLAS Life Sciences Group, Inc. (1.02), less than Third Harmonic Bio, Inc. (41.13), less than Cullinan Oncology, Inc. (28.87), less than Edgewise Therapeutics, Inc. (30.24), less than Rallybio Corporation (7.52), less than Monte Rosa Therapeutics, Inc. (6.56), less than Tyra Biosciences, Inc. (36.46), less than C4 Therapeutics, Inc. (5.09), less than Stoke Therapeutics, Inc. (6.67), less than Revolution Medicines, Inc. (15.42), less than Opthea Limited (2.94), less than Inhibrx, Inc. (6.20), less than Mineralys Therapeutics, Inc. (11.20), less than Eliem Therapeutics, Inc. (60.41), less than Anebulo Pharmaceuticals, Inc. (5.32), less than Nuvation Bio Inc. (11.49), less than Instil Bio, Inc. (15.06), less than Connect Biopharma Holdings Limited (12.04), less than Neoleukin Therapeutics, Inc. (15.33), less than Graphite Bio, Inc. (11.47),

Build a custom stock screener for Valneva SE (VALN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Valneva SE using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Valneva SE (VALN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Valneva SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.